SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367644-20-000006
Filing Date
2020-02-18
Accepted
2020-02-18 06:21:24
Documents
15
Period of Report
2020-02-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ebs-2020x02x18confiden.htm   iXBRL 8-K 56734
2 EXHIBIT 10 ex102020-2022psuagreement.htm EX-10 19434
  Complete submission text file 0001367644-20-000006.txt   230962

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebs-20200211.xsd EX-101.SCH 4630
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ebs-20200211_cal.xml EX-101.CAL 662
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ebs-20200211_def.xml EX-101.DEF 1512
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebs-20200211_lab.xml EX-101.LAB 27263
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebs-20200211_pre.xml EX-101.PRE 14152
14 EXTRACTED XBRL INSTANCE DOCUMENT ebs-2020x02x18confiden_htm.xml XML 4654
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 20623284
SIC: 2834 Pharmaceutical Preparations